Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors

por Barrière, J., Chamorey, E., Adjtoutah, Z., Castelnau, O., Mahamat, A., Marco, S., Petit, E., Leysalle, A., Raimondi, V., Carles, M.
Publicado 2021

P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT

por Storti, P., Marchica, V., Vescovini, R., Franceschi, V., Russo, L., Raimondi, V., Toscani, D., Burroughs Garcia, J., Iannozzi, N. T., Dalla Palma, B., Giaimo, M. T., Notarfranchi, L., Donofrio, G., Giuliani, N.
Publicado 2022